Letter: Addition of Methotrexate Neither Restores Clinical Response Nor Improves the Pharmacokinetic Profile of Vedolizumab-Treated Patients
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14320
Full Text
Open PDFAbstract
Available in full text
Date
October 20, 2017
Authors
Publisher
Wiley